1.Bjorklund, A, et al. Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation. Bone Marrow Transplantation 2007; 40: 1055–1062.
2.Locksley, RM, et al. Infection with varicella-zoster virus after marrow transplantation. Journal of Infectious Diseases 1985; 152: 1172–1181.
3.Schuchter, LM, et al. Herpes zoster infection after autologous bone marrow transplantation. Blood 1989; 74: 1424–1427.
4.Atkinson, K, et al. Varicella-zoster virus infection after marrow transplantation for aplastic anemia or leukemia. Transplantation 1980; 29: 47–50.
5.Berman, JN, et al. Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience. Bone Marrow Transplantation 2006; 37: 73–80.
6.Leung, TF, et al. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplantation 2000; 25: 167–172.
7.Koc, Y, et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biology of Blood and Marrow Transplantation 2000; 6: 44–49.
8.Sauerbrei, A, et al. Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplantation 1997; 20: 381–383.
9.Kawasaki, H, Takayama, J, Ohira, M. Herpes zoster infection after bone marrow transplantation in children. Journal of Pediatrics 1996; 128: 353–356.
10.Tzeng, CH, et al. Varicella zoster virus infection after allogeneic or autologous hemopoietic stem cell transplantation. Journal of the Formosa Medical Association 1995; 94: 313–317.
11.Han, CS, et al. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplantation 1994; 13: 277–283.
12.Kim, DH, et al. Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders. Transplant Infectious Disease 2008; 10: 90–98.
13.Steer, CB, et al. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir. Bone Marrow Transplantation 2000; 25: 657–664.
14.Ljungman, P, et al. Long term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro. Bone Marrow Transplantation 1986; 1: 185–192.
15.Selby, PJ, et al. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. British Journal of Cancer 1989; 59: 434–438.
16.Boeckh, M, et al. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation – a randomized double-blind placebo-controlled study. Blood 2006; 107: 1800–1805.
17.Erard, V, et al. One year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. Blood 2007; 110: 3071–3077.
18.Kanra, G, et al. Varicella seroprevalence among Turkish medical students and the validity of disease history. Infection Control and Hospital Epidemiology 2003; 24: 795–796.
19.Kamani, N, et al. Immune reconstitution after autologous purged bone marrow transplantation in children. Journal of Pediatric Hematology/Oncology 2000; 22: 13–19.
20.Storek, J, Witherspoon, RP, Storb, R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplantation 1995; 16: 413–425.
21.Foot, AB, et al. Immune reconstitution after BMT in children. Bone Marrow Transplantation 1993; 11: 7–13.
22.Atkinson, K. Reconstruction of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplantation 1990; 5: 209–226.
23.Velardi, A, et al. Imbalances within the peripheral blood T-helper (CD4+) and T-suppressor (CD8+) cell populations in the reconstitution phase after human bone marrow transplantation. Blood 1988; 71: 1196–1200.
24.Kalwak, K, et al. Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. British Journal of Haematology 2002; 118: 74–89.
25.Takaue, Y, et al. Regeneration of immunity and varicella-zoster virus infection after high-dose chemotherapy and peripheral blood stem cell autografts in children. Bone Marrow Transplantation 1994; 14: 219–223.
26.Lisse, IM, et al. T-lymphocyte subsets and eosinophil counts in acute and convalescence chickenpox infection: a household study in Guinea-Bissau. Journal of Infection 2005; 50: 125–129.